Dr. Sujuan Ba, Ph.D., President & CEO of the Asian Fund for Cancer Research (AFCR), was elected as President (2010-2011) of the Chinese Biopharmaceutical Association-USA (CBA) on June 12, 2010. Dr. Ba founded AFCR in 2006 and has held the position of President & CEO since that time.

Dr. Ba oversees AFCR's strategic operations, fundraising efforts, partnership development. Since the founding of AFCR, Dr. Ba recognized that a cure for cancer could only be achieved through collaboration, and organized the establishment of a powerful international network. This network focuses on clearly identifiable and critical aspects of cancer research, uniting scientists from a broad array of backgrounds and allowing them more freedom to explore innovative ideas.

The Chinese Biopharmaceutical Association-USA is one of the largest Chinese American professional associations in the United States. Founded in 1995, CBA is an independent, non-political, not for-profit professional organization dedicated to promoting science, technology, and business development in the biopharmaceutical fields by fostering research and business collaborations around the world. The Association is led by its elected board of directors and executive committee. For more information about the CBA and its programs, visit www.cba-usa.org.